Safety and efficacy of natalizumab in children with multiple sclerosis
Angelo Ghezzi, Gıancarlo Comı(Casa di Cura Columbus), Lucia Moiola(Vita-Salute San Raffaele University), Paola Sarchielli(University of Perugia), Luigi Grimaldi(Fondazione Istituto G. Giglio di Cefalù), Ruggero Capra(Presidio Ospedaliero), Mariarosa Rottoli(University of Bergamo), F. Bortolon(Associazione Italiana Sclerosi Multipla), Carlo Pozzilli(Sapienza University of Rome), Maria A. Rocca(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Vincenzo Brescia Morra(Federico II University Hospital), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla)
Cited by 93
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k